<DOC>
	<DOCNO>NCT01222156</DOCNO>
	<brief_summary>The Magnetecs Catheter Guidance Control Imaging ( CGCI ) system magnetic remote navigation system comprise magnetic chamber eight electromagnet around patient torso . The system change magnetic field almost instantaneously enable almost real time manipulation special magnetic catheter ( Maxwell mapping catheter ) result accurate , repeatable , rapid safe target acquisition within four chamber human heart . The trial prospective , non-randomized , clinical one design test study hypothesis ( ) technical equivalence study device comparison magnetic remote navigation system , ( b ) performance equivalence non-inferiority study device target acquisition capability compare presently use catheter navigation technique , ( c ) safety equivalence non-inferiority study device comparison catheter navigation device use navigation technique .</brief_summary>
	<brief_title>Accuracy Safety Study Magnetecs CGCI System Intracardiac Mapping</brief_title>
	<detailed_description>The CGCI system comprise ( ) magnetic chamber eight electromagnet around patient torso , ( b ) Maxwell © , 7Fr . Inquiry™ catheter attach magnetic pellet manufacture St. Jude Medical , Inc . The Maxwell © equivalent 7 Fr . Inquiry™ clear 510 ( K ) K022380 , ( c ) Agilis ES Active Sheath© modify 7.5 Fr . Steerable Introducer equivalent Agilis NxT™ Steerable Introducer , manufacture St. Jude Medical , Inc. clear 510 ( K ) K061363 . Study Rationale : Current manual manipulation map catheter imprecise difficult control . The Magnetecs CGCI system enable almost real time manipulation Maxwell mapping catheter result accurate , repeatable , rapid safe target acquisition . The CGCI System intend navigate magnetic catheter within four chamber human heart orient move catheter tip designate anatomically significant target . Design : A prospective , non-randomized , clinical trial design test study hypothesis ( ) technical equivalence study device comparison magnetic remote navigation system , ( b ) performance equivalence non-inferiority study device target acquisition capability compare presently use catheter navigation technique , ( c ) safety equivalence non-inferiority study device comparison catheter navigation device use navigation technique . Target Population : Patients recurrent cardiac rhythm disturbance meet clinically recognize indication performance intracardiac mapping procedure . Planned Number Subjects : A total 40 patient Study Objectives : This study design collect data test target acquisition performance efficacy safety CGCI intracardiac navigation . The objective achieve navigation performance criterion primary efficacy endpoint reach preselected anatomically significant target right leave heart chamber , respectively . The secondary efficacy endpoint obtain measurement stimulation threshold select anatomic site , analyze surface intracardiac signal recording target acquisition CGCI magnetic system . The primary safety endpoint define rate procedure relate incidence serious acute Adverse Events due manipulation magnetic catheter . Verification adverse event fluoroscopy , echocardiograms physician observation , result subject statistical evaluation . The claim substantial technical equivalence magnetic remote navigation system verify collect data outset clinical procedure , measure maximum magnetic field strength center region around outside perimeter CGCI device , measure maximum force available catheter tip . Success evaluate accordance primary efficacy safety endpoint specification , technical equivalency test . Data collection sample size define comply FDA ( 1992 ) 80/20 rule adequately power hypothesis test . Investigational Site : Hospital Universitario La Paz P. Castellana , 216 . 28046 Madrid , Spain Tel/ Fax : + 34 917277564 Participating Physicians : Dr. Jose Luis Merino , Dr. Vivek Reddy , Dr. Eli Gang , Dr. Armando Perez Silva , Dr. Sara Moreno Reviriego , Dr. Sergio Castrejon , Dr. Alejandro Estrada , Dr. David Doiny , Dr. Bich-Lien Nguyen , Dr. Petr Neuzil , Dr. Andre D'Avila .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Tachycardia , Supraventricular</mesh_term>
	<criteria>1 . Patients clinically eligible catheter base therapy cardiac arrhythmia 2 . Body Mass Index ( BMI ) &lt; 40 3 . Signed Informed Consent 1 . Indication atrial fibrillation ablation 2 . Indication ischemic ventricular tachycardia ablation 3 . Severe cerebrovascular disease 4 . Serum creatinine &gt; 2.5 5 . Active gastrointestinal bleeding 6 . Active infection fever 7 . Short life expectancy ( &lt; 6 month ) 8 . Severe uncontrolled systemic hypertension 9 . Severe electrolyte imbalance 10 . Congestive heart failure ( NYHA Class IV ) 11 . Unstable angina 12 . Recent MI ( &lt; 4 week ) 13 . Bleeding clot disorder 14 . Uncontrolled diabetes 15 . Inability receive IV Anticoagulants 16 . Presence intracardiac thrombus 17 . Patients prosthetic cardiac valve 18 . Patients permanent pacemaker ICD 's 19 . Pregnancy 20 . Enrollment ongoing clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Cardiac arrhythmia</keyword>
	<keyword>Catheter ablation</keyword>
	<keyword>Electrophysiology</keyword>
	<keyword>Magnetic</keyword>
	<keyword>Mapping</keyword>
	<keyword>Remote navigation</keyword>
</DOC>